Avelox is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Redpharm Drug Inc.. The primary component is Moxifloxacin Hydrochloride.
Product ID | 67296-0154_4c8fe3c9-0537-4fda-aef5-918f0a961a8b |
NDC | 67296-0154 |
Product Type | Human Prescription Drug |
Proprietary Name | Avelox |
Generic Name | Moxifloxacin Hydrochloride |
Dosage Form | Tablet, Film Coated |
Route of Administration | ORAL |
Marketing Start Date | 2011-02-25 |
Marketing Category | NDA / NDA |
Application Number | NDA021085 |
Labeler Name | RedPharm Drug Inc. |
Substance Name | MOXIFLOXACIN HYDROCHLORIDE |
Active Ingredient Strength | 400 mg/1 |
Pharm Classes | Quinolone Antimicrobial [EPC],Quinolones [CS] |
NDC Exclude Flag | E |
Listing Certified Through | 2017-12-31 |
Marketing Start Date | 2011-02-25 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA021085 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2011-02-25 |
Inactivation Date | 2019-10-29 |
Marketing Category | NDA |
Application Number | NDA021085 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2011-02-25 |
Inactivation Date | 2019-10-29 |
Marketing Category | NDA |
Application Number | NDA021085 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2011-02-25 |
Inactivation Date | 2019-10-29 |
Ingredient | Strength |
---|---|
MOXIFLOXACIN HYDROCHLORIDE | 400 mg/1 |
SPL SET ID: | fe9226f8-64f4-4eff-8339-ed3fce0896f2 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
0085-1733 | Avelox | moxifloxacin hydrochloride |
0085-1737 | Avelox | moxifloxacin hydrochloride |
50419-530 | Avelox | Avelox |
50419-537 | Avelox | Avelox |
67296-0154 | Avelox | Avelox |
0065-0006 | MOXEZA | moxifloxacin hydrochloride |
48792-7823 | Moxifloxacin | moxifloxacin hydrochloride |
0093-7387 | Moxifloxacin Hydrochloride | Moxifloxacin Hydrochloride |
0832-1410 | Moxifloxacin Hydrochloride | Moxifloxacin Hydrochloride |
13668-201 | moxifloxacin hydrochloride | moxifloxacin hydrochloride |
40032-034 | Moxifloxacin Hydrochloride | Moxifloxacin Hydrochloride |
43063-580 | Moxifloxacin Hydrochloride | moxifloxacin hydrochloride |
43063-585 | Moxifloxacin Hydrochloride | moxifloxacin hydrochloride |
47781-268 | Moxifloxacin Hydrochloride | moxifloxacin hydrochloride |
50090-4058 | Moxifloxacin Hydrochloride | Moxifloxacin Hydrochloride |
50090-4100 | Moxifloxacin Hydrochloride | Moxifloxacin Hydrochloride |
0781-7135 | Moxifloxacin Ophthalmic Solution | moxifloxacin hydrochloride |
0065-4013 | VIGAMOX | moxifloxacin hydrochloride |
0078-0939 | VIGAMOX | moxifloxacin hydrochloride |
21695-968 | VIGAMOX | moxifloxacin hydrochloride |
50090-0859 | VIGAMOX | moxifloxacin hydrochloride |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
AVELOX 78092603 2780658 Live/Registered |
Bayer Aktiengesellschaft 2001-11-09 |
AVELOX 75400008 2373382 Live/Registered |
Bayer Aktiengesellschaft 1997-12-04 |